Advent Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-5,000
Closed -$459K – 293
2021
Q4
$459K Buy
+5,000
New +$598K 0.01% 238
2021
Q3
– Sell
-18,300
Closed -$3.04M – 288
2021
Q2
$3.04M Buy
18,300
+18,263
+49,359% +$2.96M 0.06% 164
2021
Q1
$7K Buy
+37
New +$8.58K ﹤0.01% 234
2019
Q3
– Sell
-8,000
Closed -$531K – 236
2019
Q2
$531K Sell
8,000
-37,000
-82% -$2.16M 0.01% 169
2019
Q1
$2.5M Buy
45,000
+10,000
+29% +$611K 0.06% 149
2018
Q4
$1.74M Buy
+35,000
New +$2.14M 0.04% 155

Other funds holding TDOC

Advent Capital Management's TDOC Position: Q1 2022 in Review

Advent Capital Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 5,000 shares — an estimated $459K sold.

Advent Capital Management first reported a position in TDOC in Q4 2018 and held it in 6 quarters. The position peaked at $3.04M in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Advent Capital Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Advent Capital Management sold 5,000 Teladoc Health shares in Q1 2022, an estimated $459K.
  • Advent Capital Management first reported a position in Teladoc Health in Q4 2018 and held it in 6 quarters.
  • Advent Capital Management's Teladoc Health position peaked at $3.04M in Q2 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Advent Capital Management's 13F filing for Q1 2022, filed 13 May 2022.